Investment Analysts’ price target changes for Monday, November 16th:
AbbVie (NYSE:ABBV) had its target price boosted by Barclays from $325.00 to $335.00. The firm currently has an overweight rating on the stock.
AbCellera Biologics (NASDAQ:ABCL) had its price target increased by Piper Sandler from $12.00 to $20.00. Piper Sandler currently has an overweight rating on the stock.
Absci (NASDAQ:ABSI) had its price target reduced by Guggenheim from $15.00 to $14.00. They currently have a buy rating on the stock.
Array Digital Infrastructure (NYSE:AD) had its target price cut by Royal Bank Of Canada from $40.00 to $33.00. The firm currently has a sector perform rating on the stock.
Array Digital Infrastructure (NYSE:AD) had its target price lowered by JPMorgan Chase & Co. from $45.00 to $43.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Agree Realty (NYSE:ADC) had its target price boosted by Wells Fargo & Company from $79.00 to $81.00. They currently have an overweight rating on the stock.
ADI Global Distribution Inc. Common Stock (NYSE:ADIG) had its price target cut by Truist Financial from $24.00 to $11.00. The firm currently has a hold rating on the stock.
Addus HomeCare (NASDAQ:ADUS) had its price target boosted by Royal Bank Of Canada from $134.00 to $141.00. The firm currently has an outperform rating on the stock.
Aetherion Technologies (NASDAQ:AETR) had its price target raised by Royal Bank Of Canada from $1.00 to $1.75. Royal Bank Of Canada currently has a sector perform rating on the stock.
Assurant (NYSE:AIZ) had its target price increased by Morgan Stanley from $330.00 to $360.00. The firm currently has an overweight rating on the stock.
Arthur J. Gallagher & Co. (NYSE:AJG) had its price target raised by Morgan Stanley from $295.00 to $325.00. They currently have an overweight rating on the stock.
Akebia Therapeutics (NASDAQ:AKBA) had its price target cut by Piper Sandler to $2.00. They currently have an overweight rating on the stock.
Allstate (NYSE:ALL) had its price target cut by JPMorgan Chase & Co. from $292.00 to $291.00. The firm currently has an overweight rating on the stock.
Alumis (NASDAQ:ALMS) had its price target trimmed by Oppenheimer to $28.00. The firm currently has an outperform rating on the stock.
Amgen (NASDAQ:AMGN) had its price target boosted by Barclays from $400.00 to $430.00. The firm currently has an equal weight rating on the stock.
Amaroq Minerals (LON:AMRQ) had its price target raised by Canaccord Genuity Group from GBX 140 to GBX 160. They currently have a buy rating on the stock.
Amrize (NYSE:AMRZ) had its price target boosted by UBS Group from $42.00 to $46.00. The firm currently has a neutral rating on the stock.
AON (NYSE:AON) had its price target raised by Morgan Stanley from $350.00 to $385.00. They currently have an overweight rating on the stock.
Alexandria Real Estate Equities (NYSE:ARE) had its target price reduced by Mizuho from $60.00 to $50.00. Mizuho currently has an outperform rating on the stock.
argenex (NASDAQ:ARGX) had its target price increased by Piper Sandler from $1,215.00 to $1,350.00. They currently have an overweight rating on the stock.
Ascendis Pharma A/S (NASDAQ:ASND) had its price target increased by Barclays from $329.00 to $341.00. They currently have an overweight rating on the stock.
Aviva (LON:AV) had its target price raised by Berenberg Bank from GBX 820 to GBX 850. Berenberg Bank currently has a buy rating on the stock.
ArriVent BioPharma (NASDAQ:AVBP) had its price target cut by Guggenheim from $30.00 to $28.00. Guggenheim currently has a buy rating on the stock.
Atea Pharmaceuticals (NASDAQ:AVIR) had its price target raised by Morgan Stanley from $7.00 to $8.00. They currently have an equal weight rating on the stock.
Avalyn Pharma (NASDAQ:AVLN) had its price target lowered by Morgan Stanley from $57.00 to $53.00. The firm currently has an overweight rating on the stock.
Credicorp (NYSE:BAP) had its target price increased by JPMorgan Chase & Co. from $482.00 to $490.00. The firm currently has an overweight rating on the stock.
Bullish (NYSE:BLSH) had its target price reduced by Wells Fargo & Company from $35.00 to $28.00. They currently have an equal weight rating on the stock.
Benitec Biopharma (NASDAQ:BNTC) had its price target boosted by Wedbush from $17.00 to $20.00. The firm currently has an outperform rating on the stock.
Benitec Biopharma (NASDAQ:BNTC) had its price target raised by Leerink Partners from $18.00 to $18.27. Leerink Partners currently has an outperform rating on the stock.
BP (NYSE:BP) had its target price increased by Argus from $50.00 to $53.00. The firm currently has a buy rating on the stock.
Brown & Brown (NYSE:BRO) had its target price increased by Morgan Stanley from $55.00 to $60.00. They currently have an underweight rating on the stock.
Bit Digital (NASDAQ:BTBT) had its target price lowered by B. Riley Financial to $3.50. The firm currently has a buy rating on the stock.
Burlington Stores (NYSE:BURL) had its target price cut by Morgan Stanley from $432.00 to $381.00. Morgan Stanley currently has an overweight rating on the stock.
BrightView (NYSE:BV) had its target price lowered by Oppenheimer from $16.00 to $13.00. The firm currently has an outperform rating on the stock.
Chubb (NYSE:CB) had its price target raised by Morgan Stanley from $360.00 to $380.00. They currently have an equal weight rating on the stock.
CBRE Group (NYSE:CBRE) had its target price trimmed by Barclays from $183.00 to $161.00. Barclays currently has an overweight rating on the stock.
COPT Defense Properties (NYSE:CDP) had its target price reduced by Wells Fargo & Company from $41.00 to $36.00. Wells Fargo & Company currently has an overweight rating on the stock.
CDW (NASDAQ:CDW) had its price target boosted by Barclays from $148.00 to $164.00. The firm currently has an equal weight rating on the stock.
Citizens Financial Group (NYSE:CFG) had its target price increased by Cantor Fitzgerald from $78.00 to $80.00. They currently have an overweight rating on the stock.
Cognex (NASDAQ:CGNX) had its price target reduced by Barclays from $85.00 to $76.00. The firm currently has an overweight rating on the stock.
Cummins (NYSE:CMI) had its price target cut by Morgan Stanley from $761.00 to $588.00. They currently have an overweight rating on the stock.
Collegium Pharmaceutical (NASDAQ:COLL) had its target price trimmed by Barclays from $48.00 to $41.00. They currently have an overweight rating on the stock.
Croda International (LON:CRDA) had its price target raised by Deutsche Bank from GBX 3,300 to GBX 4,100. The firm currently has a buy rating on the stock.
Corsair Gaming (NASDAQ:CRSR) had its price target raised by Wedbush from $16.00 to $17.00. Wedbush currently has an outperform rating on the stock.
CareTrust REIT (NYSE:CTRE) had its price target cut by KeyCorp from $46.00 to $43.00. KeyCorp currently has an overweight rating on the stock.
CareTrust REIT (NYSE:CTRE) had its target price raised by Wells Fargo & Company from $43.00 to $44.00. The firm currently has an overweight rating on the stock.
CareTrust REIT (NYSE:CTRE) had its price target trimmed by Mizuho from $45.00 to $44.00. The firm currently has an outperform rating on the stock.
Corteva (NYSE:CTVA) had its price target cut by KeyCorp from $17.00 to $14.00. KeyCorp currently has an overweight rating on the stock.
Cousins Properties (NYSE:CUZ) had its price target raised by Wells Fargo & Company from $34.00 to $35.00. The firm currently has an overweight rating on the stock.
CVS Health (NYSE:CVS) had its target price lowered by Royal Bank Of Canada from $113.00 to $108.00. Royal Bank Of Canada currently has an outperform rating on the stock.
Cushman & Wakefield (NYSE:CWK) had its price target trimmed by Barclays from $16.00 to $15.00. Barclays currently has an equal weight rating on the stock.
Dell Technologies (NYSE:DELL) had its target price lowered by Morgan Stanley from $511.00 to $403.00. They currently have an equal weight rating on the stock.
DFS Furniture (LON:DFS) had its price target cut by Berenberg Bank from GBX 210 to GBX 180. Berenberg Bank currently has a buy rating on the stock.
Dollar Tree (NASDAQ:DLTR) had its target price raised by UBS Group from $150.00 to $165.00. The firm currently has a buy rating on the stock.
Healthpeak Properties (NYSE:DOC) had its price target lowered by Mizuho from $24.00 to $23.00. Mizuho currently has an outperform rating on the stock.
Healthpeak Properties (NYSE:DOC) had its target price raised by Wells Fargo & Company from $19.00 to $20.00. They currently have an equal weight rating on the stock.
DPC (NYSE:DPC) had its target price raised by Morgan Stanley from $43.00 to $47.00. They currently have an equal weight rating on the stock.
DPC (NYSE:DPC) had its target price boosted by Barclays from $49.00 to $50.00. They currently have an overweight rating on the stock.
Devon Energy (NYSE:DVN) had its target price lowered by Seaport Research Partners from $65.00 to $57.00. The firm currently has a buy rating on the stock.
Eagle Point Credit (NYSE:ECC) had its price target lowered by B. Riley Financial from $4.50 to $4.00. B. Riley Financial currently has a buy rating on the stock.
Equifax (NYSE:EFX) had its target price boosted by Needham & Company LLC from $210.00 to $220.00. They currently have a buy rating on the stock.
Equifax (NYSE:EFX) had its price target raised by Mizuho from $185.00 to $212.00. Mizuho currently has an outperform rating on the stock.
EPR Properties (NYSE:EPR) had its price target raised by Wells Fargo & Company from $56.00 to $62.00. Wells Fargo & Company currently has an equal weight rating on the stock.
Essential Properties Realty Trust (NYSE:EPRT) had its price target raised by Wells Fargo & Company from $30.00 to $32.00. Wells Fargo & Company currently has an overweight rating on the stock.
Edwards Lifesciences (NYSE:EW) had its price target boosted by Wells Fargo & Company from $113.00 to $121.00. They currently have an overweight rating on the stock.
East West Bancorp (NASDAQ:EWBC) had its price target increased by Cantor Fitzgerald from $146.00 to $148.00. They currently have an overweight rating on the stock.
Expand Energy (NASDAQ:EXE) had its target price reduced by The Goldman Sachs Group from $117.00 to $103.00. The firm currently has a buy rating on the stock.
Extra Space Storage (NYSE:EXR) had its price target boosted by Barclays from $172.00 to $173.00. The firm currently has an overweight rating on the stock.
Four Corners Property Trust (NYSE:FCPT) had its target price raised by Wells Fargo & Company from $22.00 to $23.00. Wells Fargo & Company currently has an equal weight rating on the stock.
First Financial Bankshares (NASDAQ:FFIN) had its target price lowered by Cantor Fitzgerald from $34.00 to $33.00. They currently have a neutral rating on the stock.
Figure Technology Solutions (NASDAQ:FIGR) had its target price trimmed by Mizuho from $55.00 to $46.00. Mizuho currently has an outperform rating on the stock.
Fiserv (NASDAQ:FISV) had its price target raised by Robert W. Baird from $70.00 to $85.00. They currently have an outperform rating on the stock.
FrontView REIT (NYSE:FVR) had its target price raised by Wells Fargo & Company from $20.00 to $22.00. Wells Fargo & Company currently has an overweight rating on the stock.
Gemini Space Station (NASDAQ:GEMI) had its price target trimmed by The Goldman Sachs Group from $4.25 to $3.75. They currently have a sell rating on the stock.
Gemini Space Station (NASDAQ:GEMI) had its target price reduced by Needham & Company LLC from $6.50 to $6.00. Needham & Company LLC currently has a buy rating on the stock.
Gilead Sciences (NASDAQ:GILD) had its price target raised by Barclays from $145.00 to $160.00. They currently have an equal weight rating on the stock.
Glaukos (NYSE:GKOS) had its target price raised by BTIG Research from $234.00 to $252.00. The firm currently has a buy rating on the stock.
Globe Life (NYSE:GL) had its target price raised by TD Cowen from $215.00 to $218.00. They currently have a buy rating on the stock.
Gaming and Leisure Properties (NASDAQ:GLPI) had its price target trimmed by Wells Fargo & Company from $40.00 to $39.00. Wells Fargo & Company currently has an equal weight rating on the stock.
Galaxy Digital (NASDAQ:GLXY) had its target price trimmed by Piper Sandler from $25.00 to $24.00. The firm currently has an overweight rating on the stock.
Goosehead Insurance (NASDAQ:GSHD) had its target price trimmed by Keefe, Bruyette & Woods from $66.00 to $60.00. Keefe, Bruyette & Woods currently has an outperform rating on the stock.
W.W. Grainger (NYSE:GWW) had its price target raised by Morgan Stanley from $1,400.00 to $1,590.00. They currently have an equal weight rating on the stock.
W.W. Grainger (NYSE:GWW) had its target price boosted by Barclays from $1,172.00 to $1,355.00. The firm currently has an underweight rating on the stock.
Hyatt Hotels (NYSE:H) had its target price boosted by Sanford C. Bernstein from $202.00 to $231.00. They currently have an outperform rating on the stock.
Haemonetics (NYSE:HAE) had its price target raised by Citizens Jmp from $115.00 to $144.00. Citizens Jmp currently has a market outperform rating on the stock.
Hasbro (NASDAQ:HAS) had its target price raised by Wells Fargo & Company from $100.00 to $115.00. They currently have an equal weight rating on the stock.
Hasbro (NASDAQ:HAS) had its target price boosted by JPMorgan Chase & Co. from $111.00 to $145.00. The firm currently has an overweight rating on the stock.
HawkEye 360 (NYSE:HAWK) had its target price increased by Morgan Stanley from $25.00 to $26.00. They currently have an overweight rating on the stock.
HudBay Minerals (NYSE:HBM) (TSE:HBM) had its target price cut by Barclays from $32.00 to $31.00. The firm currently has an overweight rating on the stock.
Hilton Worldwide (NYSE:HLT) had its price target raised by Sanford C. Bernstein from $320.00 to $380.00. Sanford C. Bernstein currently has a market perform rating on the stock.
HMH (NASDAQ:HMH) had its target price reduced by Stifel Nicolaus from $28.00 to $25.00. The firm currently has a buy rating on the stock.
Hewlett Packard Enterprise (NYSE:HPE) had its price target trimmed by Morgan Stanley from $72.00 to $64.00. They currently have an overweight rating on the stock.
HP (NYSE:HPQ) had its target price raised by Morgan Stanley from $19.00 to $21.00. They currently have an underweight rating on the stock.
Healthcare Realty Trust (NYSE:HR) had its price target boosted by Wells Fargo & Company from $18.00 to $19.00. Wells Fargo & Company currently has an equal weight rating on the stock.
Hut 8 (NASDAQ:HUT) had its target price trimmed by Piper Sandler from $123.00 to $115.00. Piper Sandler currently has an overweight rating on the stock.
Hancock Whitney (NASDAQ:HWC) had its target price trimmed by Keefe, Bruyette & Woods from $79.00 to $72.00. They currently have a market perform rating on the stock.
Installed Building Products (NYSE:IBP) had its price target increased by Truist Financial from $180.00 to $220.00. Truist Financial currently has a hold rating on the stock.
Installed Building Products (NYSE:IBP) had its target price increased by Royal Bank Of Canada from $194.00 to $215.00. They currently have a sector perform rating on the stock.
Intercontinental Exchange (NYSE:ICE) had its price target raised by Argus from $187.00 to $198.00. The firm currently has a buy rating on the stock.
Intercontinental Hotels Group (NYSE:IHG) had its target price increased by Sanford C. Bernstein from $154.00 to $177.00. They currently have a market perform rating on the stock.
Immix Biopharma (NASDAQ:IMMX) had its target price raised by HC Wainwright from $25.00 to $27.00. HC Wainwright currently has a buy rating on the stock.
Inhibrx Biosciences (NASDAQ:INBX) had its target price reduced by HC Wainwright from $245.00 to $220.00. The firm currently has a buy rating on the stock.
Inter & Co. Inc. (NASDAQ:INTR) had its price target lowered by The Goldman Sachs Group from $9.00 to $8.00. The firm currently has a buy rating on the stock.
Innoviz Technologies (NASDAQ:INVZ) had its price target cut by The Goldman Sachs Group from $0.40 to $0.20. They currently have a neutral rating on the stock.
Samsara (NYSE:IOT) had its price target lowered by Truist Financial from $48.00 to $41.00. They currently have a hold rating on the stock.
Quince Therapeutics (NASDAQ:IRLA) had its price target boosted by Citizens Jmp from $77.00 to $86.00. The firm currently has a market outperform rating on the stock.
Itau Unibanco (NYSE:ITUB) had its price target reduced by JPMorgan Chase & Co. from $10.00 to $9.00. The firm currently has an overweight rating on the stock.
Janus Living (NYSE:JAN) had its target price increased by Wells Fargo & Company from $34.00 to $36.00. The firm currently has an overweight rating on the stock.
Jade Biosciences (NASDAQ:JBIO) had its target price lowered by Guggenheim from $47.00 to $41.00. The firm currently has a buy rating on the stock.
Jernigan Capital (NASDAQ:JCAP) had its price target increased by Keefe, Bruyette & Woods from $30.00 to $32.00. They currently have an outperform rating on the stock.
Jones Lang LaSalle (NYSE:JLL) had its price target boosted by Barclays from $401.00 to $404.00. They currently have an equal weight rating on the stock.
Kraft Heinz (NASDAQ:KHC) had its price target trimmed by Barclays from $25.00 to $24.00. Barclays currently has an equal weight rating on the stock.
KinderCare Learning Companies (NYSE:KLC) had its price target cut by Barclays from $3.00 to $1.50. They currently have an underweight rating on the stock.
Kennametal (NYSE:KMT) had its target price cut by Morgan Stanley from $27.00 to $20.00. The firm currently has an underweight rating on the stock.
Kinsale Capital Group (NYSE:KNSL) had its price target boosted by Morgan Stanley from $350.00 to $400.00. Morgan Stanley currently has an equal weight rating on the stock.
Kinetik (NYSE:KNTK) had its target price increased by Royal Bank Of Canada from $58.00 to $62.00. The firm currently has an outperform rating on the stock.
Lifeward (NASDAQ:LFWD) had its price target lowered by HC Wainwright from $10.00 to $8.00. The firm currently has a buy rating on the stock.
Lineage (NASDAQ:LINE) had its target price cut by Truist Financial from $46.00 to $41.00. They currently have a buy rating on the stock.
Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) had its target price raised by Morgan Stanley from $26.00 to $27.00. They currently have an equal weight rating on the stock.
Eli Lilly and Company (NYSE:LLY) had its price target raised by Barclays from $1,400.00 to $1,550.00. Barclays currently has an overweight rating on the stock.
Lemonade (NYSE:LMND) had its target price reduced by Morgan Stanley from $48.00 to $45.00. They currently have an equal weight rating on the stock.
London Stock Exchange Group (LON:LSEG) had its target price increased by Deutsche Bank from £110 to £114. Deutsche Bank currently has a buy rating on the stock.
Marriott International (NASDAQ:MAR) had its target price increased by Sanford C. Bernstein from $445.00 to $479.00. Sanford C. Bernstein currently has an outperform rating on the stock.
MARA (NASDAQ:MARA) had its target price reduced by Piper Sandler from $11.00 to $10.00. Piper Sandler currently has an overweight rating on the stock.
Milestone Pharmaceuticals (NASDAQ:MIST) had its target price lowered by Piper Sandler to $3.00. Piper Sandler currently has an overweight rating on the stock.
Martin Marietta Materials (NYSE:MLM) had its target price trimmed by Morgan Stanley from $639.00 to $590.00. They currently have an overweight rating on the stock.
3M (NYSE:MMM) had its target price boosted by Wells Fargo & Company from $195.00 to $205.00. Wells Fargo & Company currently has an equal weight rating on the stock.
Monopar Therapeutics (NASDAQ:MNPR) had its price target boosted by Morgan Stanley from $130.00 to $133.00. They currently have an overweight rating on the stock.
Marsh & McLennan Companies (NYSE:MRSH) had its target price increased by Morgan Stanley from $190.00 to $215.00. They currently have an equal weight rating on the stock.
MSC Income Fund (NYSE:MSIF) had its price target lowered by Keefe, Bruyette & Woods from $15.50 to $15.00. Keefe, Bruyette & Woods currently has an outperform rating on the stock.
MasTec (NYSE:MTZ) had its target price cut by Guggenheim from $518.00 to $335.00. The firm currently has a buy rating on the stock.
SOLV Energy (NASDAQ:MWH) had its price target boosted by TD Cowen from $35.00 to $37.00. They currently have a buy rating on the stock.
KindlyMD (NASDAQ:NAKA) had its target price trimmed by B. Riley Financial from $13.00 to $10.00. B. Riley Financial currently has a buy rating on the stock.
Navan (NASDAQ:NAVN) had its target price raised by TD Cowen from $30.00 to $32.00. The firm currently has a buy rating on the stock.
NextDecade (NASDAQ:NEXT) had its price target raised by TD Cowen from $7.00 to $7.50. They currently have a hold rating on the stock.
National Health Investors (NYSE:NHI) had its target price cut by Wells Fargo & Company from $68.00 to $65.00. Wells Fargo & Company currently has an equal weight rating on the stock.
Newmark Group (NASDAQ:NMRK) had its price target lowered by Barclays from $20.00 to $14.00. They currently have an overweight rating on the stock.
NNN REIT (NYSE:NNN) had its price target lowered by Wells Fargo & Company from $43.00 to $42.00. Wells Fargo & Company currently has an equal weight rating on the stock.
NeuroPace (NASDAQ:NPCE) had its price target trimmed by HC Wainwright from $20.00 to $12.00. HC Wainwright currently has a buy rating on the stock.
NRG Energy (NYSE:NRG) had its price target cut by BMO Capital Markets from $147.00 to $124.00. The firm currently has a market perform rating on the stock.
Insperity (NYSE:NSP) had its price target increased by JPMorgan Chase & Co. from $38.00 to $45.00. The firm currently has an underweight rating on the stock.
Netskope (NASDAQ:NTSK) had its price target raised by TD Cowen from $19.00 to $25.00. They currently have a buy rating on the stock.
NETSTREIT (NYSE:NTST) had its target price increased by Wells Fargo & Company from $20.00 to $21.00. The firm currently has an overweight rating on the stock.
NVIDIA (NASDAQ:NVDA) had its price target trimmed by Mizuho from $250.00 to $220.00. The firm currently has an outperform rating on the stock.
NVIDIA (NASDAQ:NVDA) had its target price cut by TD Cowen from $275.00 to $200.00. TD Cowen currently has a buy rating on the stock.
Realty Income (NYSE:O) had its price target boosted by Wells Fargo & Company from $59.00 to $61.00. Wells Fargo & Company currently has an equal weight rating on the stock.
Once Upon A Farm (NYSE:OFRM) had its target price trimmed by Barclays from $19.00 to $11.00. They currently have an equal weight rating on the stock.
Omega Healthcare Investors (NYSE:OHI) had its target price raised by Mizuho from $46.00 to $49.00. They currently have a neutral rating on the stock.
Omega Healthcare Investors (NYSE:OHI) had its target price increased by Wells Fargo & Company from $46.00 to $49.00. The firm currently has an equal weight rating on the stock.
Omega Healthcare Investors (NYSE:OHI) had its target price increased by Royal Bank Of Canada from $51.00 to $52.00. They currently have a sector perform rating on the stock.
Ondas (NASDAQ:ONDS) had its target price trimmed by Stifel Nicolaus from $18.00 to $15.00. The firm currently has a buy rating on the stock.
Blue Owl Technology Finance (NYSE:OTF) had its target price cut by Keefe, Bruyette & Woods from $12.00 to $11.50. They currently have a market perform rating on the stock.
Owlet (NYSE:OWLT) had its target price reduced by TD Cowen from $10.00 to $4.00. They currently have a buy rating on the stock.
Everpure (NYSE:P) had its price target boosted by Morgan Stanley from $137.00 to $142.00. The firm currently has an overweight rating on the stock.
PACS Group (NYSE:PACS) had its target price raised by Royal Bank Of Canada from $57.00 to $64.00. The firm currently has an outperform rating on the stock.
Pro-Dex (NASDAQ:PDEX) had its price target boosted by Ascendiant Capital Markets from $74.00 to $80.00. They currently have a buy rating on the stock.
Permian Resources (NYSE:PR) had its target price trimmed by Seaport Research Partners from $29.00 to $27.00. Seaport Research Partners currently has a buy rating on the stock.
Praxis Precision Medicines (NASDAQ:PRAX) had its target price increased by Robert W. Baird from $514.00 to $568.00. They currently have an outperform rating on the stock.
Praxis Precision Medicines (NASDAQ:PRAX) had its target price raised by Guggenheim from $800.00 to $1,050.00. Guggenheim currently has a buy rating on the stock.
Q2 (NYSE:QTWO) had its target price increased by JPMorgan Chase & Co. from $76.00 to $82.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Replimune Group (NASDAQ:REPL) had its target price raised by Piper Sandler from $14.00 to $27.00. The firm currently has an overweight rating on the stock.
Suncrete (NASDAQ:RMIX) had its target price reduced by Robert W. Baird from $17.00 to $9.00. The firm currently has an outperform rating on the stock.
Roivant Sciences (NASDAQ:ROIV) had its price target increased by Guggenheim from $46.00 to $48.00. They currently have a buy rating on the stock.
Ross Stores (NASDAQ:ROST) had its target price boosted by Morgan Stanley from $234.00 to $235.00. They currently have an equal weight rating on the stock.
Revvity (NYSE:RVTY) had its price target raised by JPMorgan Chase & Co. from $160.00 to $165.00. They currently have a neutral rating on the stock.
Ryan Specialty (NYSE:RYAN) had its price target increased by Morgan Stanley from $50.00 to $55.00. The firm currently has an overweight rating on the stock.
Sabra Healthcare REIT (NASDAQ:SBRA) had its price target boosted by Wells Fargo & Company from $21.00 to $23.00. The firm currently has an overweight rating on the stock.
Sabra Healthcare REIT (NASDAQ:SBRA) had its price target raised by Mizuho from $21.00 to $22.00. They currently have a neutral rating on the stock.
SolarEdge Technologies (NASDAQ:SEDG) had its target price lowered by Wells Fargo & Company from $36.00 to $26.00. They currently have an equal weight rating on the stock.
SiteOne Landscape Supply (NYSE:SITE) had its price target raised by Stifel Nicolaus from $102.00 to $108.00. They currently have a hold rating on the stock.
J. M. Smucker (NYSE:SJM) had its target price increased by JPMorgan Chase & Co. from $149.00 to $150.00. The firm currently has an overweight rating on the stock.
Skyward Specialty Insurance Group (NASDAQ:SKWD) had its target price raised by TD Cowen from $65.00 to $69.00. TD Cowen currently has a hold rating on the stock.
Summit Therapeutics (NASDAQ:SMMT) had its price target trimmed by Barclays from $20.00 to $18.00. Barclays currently has an equal weight rating on the stock.
Semtech (NASDAQ:SMTC) had its target price trimmed by UBS Group from $230.00 to $200.00. The firm currently has a buy rating on the stock.
Semtech (NASDAQ:SMTC) had its target price reduced by Morgan Stanley from $205.00 to $176.00. The firm currently has an equal weight rating on the stock.
Spectrum Brands (NYSE:SPB) had its target price increased by Wells Fargo & Company from $85.00 to $87.00. Wells Fargo & Company currently has an equal weight rating on the stock.
Stag Industrial (NYSE:STAG) had its price target boosted by Wells Fargo & Company from $38.00 to $39.00. The firm currently has an equal weight rating on the stock.
Steel Dynamics (NASDAQ:STLD) had its target price cut by UBS Group from $276.00 to $257.00. The firm currently has a neutral rating on the stock.
Tidewater (NYSE:TDW) had its target price trimmed by Barclays from $91.00 to $88.00. The firm currently has an equal weight rating on the stock.
Telecom Argentina Stet – France Telecom (NYSE:TEO) had its price target reduced by UBS Group from $16.50 to $15.00. They currently have a buy rating on the stock.
Target Hospitality (NASDAQ:TH) had its target price cut by Oppenheimer from $27.00 to $22.00. They currently have an outperform rating on the stock.
Target Hospitality (NASDAQ:TH) had its price target reduced by Morgan Stanley from $25.00 to $21.00. The firm currently has an overweight rating on the stock.
The Hanover Insurance Group (NYSE:THG) had its price target increased by Morgan Stanley from $235.00 to $250.00. Morgan Stanley currently has an equal weight rating on the stock.
TJX Companies (NYSE:TJX) had its price target lowered by Morgan Stanley from $178.00 to $166.00. They currently have an overweight rating on the stock.
TriNet Group (NYSE:TNET) had its target price raised by JPMorgan Chase & Co. from $50.00 to $55.00. JPMorgan Chase & Co. currently has an underweight rating on the stock.
Targa Resources (NYSE:TRGP) had its target price boosted by Stifel Nicolaus from $335.00 to $340.00. Stifel Nicolaus currently has a buy rating on the stock.
Trustmark (NASDAQ:TRMK) had its price target increased by Keefe, Bruyette & Woods from $50.00 to $54.00. The firm currently has a market perform rating on the stock.
TransUnion (NYSE:TRU) had its target price raised by Mizuho from $74.00 to $78.00. They currently have a neutral rating on the stock.
TWFG (NASDAQ:TWFG) had its price target raised by Morgan Stanley from $31.00 to $32.00. They currently have an overweight rating on the stock.
Twist Bioscience (NASDAQ:TWST) had its target price lowered by Barclays from $215.00 to $130.00. They currently have an overweight rating on the stock.
Travelzoo (NASDAQ:TZOO) had its price target reduced by Ascendiant Capital Markets from $20.00 to $18.00. The firm currently has a buy rating on the stock.
Ulta Beauty (NASDAQ:ULTA) had its target price raised by BMO Capital Markets from $580.00 to $665.00. The firm currently has a market perform rating on the stock.
Americas Gold and Silver (NYSEAMERICAN:USAS) had its price target trimmed by HC Wainwright from $9.25 to $6.75. HC Wainwright currently has a buy rating on the stock.
Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK) had its target price boosted by Royal Bank Of Canada from $67.00 to $68.00. They currently have a sector perform rating on the stock.
Corporacion Inmobiliaria Vesta (NYSE:VTMX) had its target price raised by UBS Group from $43.00 to $47.00. They currently have a buy rating on the stock.
Ventas (NYSE:VTR) had its price target cut by Mizuho from $104.00 to $101.00. Mizuho currently has an outperform rating on the stock.
Ventas (NYSE:VTR) had its target price increased by Wells Fargo & Company from $96.00 to $102.00. Wells Fargo & Company currently has an overweight rating on the stock.
Welltower (NYSE:WELL) had its price target boosted by Wells Fargo & Company from $268.00 to $283.00. Wells Fargo & Company currently has an overweight rating on the stock.
Welltower (NYSE:WELL) had its price target increased by Mizuho from $260.00 to $270.00. The firm currently has an outperform rating on the stock.
Western Midstream Partners (NYSE:WES) had its target price raised by Wells Fargo & Company from $46.00 to $47.00. Wells Fargo & Company currently has an equal weight rating on the stock.
W.P. Carey (NYSE:WPC) had its target price boosted by Wells Fargo & Company from $73.00 to $74.00. They currently have an overweight rating on the stock.
Wise Group (NASDAQ:WSE) had its price target increased by JPMorgan Chase & Co. from $17.70 to $17.80. The firm currently has an overweight rating on the stock.
Watsco (NYSE:WSO) had its target price raised by Morgan Stanley from $330.00 to $340.00. The firm currently has an equal weight rating on the stock.
Willis Towers Watson Public (NASDAQ:WTW) had its target price raised by Morgan Stanley from $325.00 to $350.00. Morgan Stanley currently has an equal weight rating on the stock.
WhiteFiber (NASDAQ:WYFI) had its price target cut by Cantor Fitzgerald from $36.00 to $24.00. Cantor Fitzgerald currently has an overweight rating on the stock.
X-Energy (NASDAQ:XE) had its price target boosted by Piper Sandler from $8.00 to $9.00. The firm currently has an underweight rating on the stock.
DENTSPLY SIRONA (NASDAQ:XRAY) had its price target trimmed by UBS Group from $17.00 to $13.00. The firm currently has a buy rating on the stock.
Zimmer Biomet (NYSE:ZBH) had its price target cut by BMO Capital Markets from $102.00 to $101.00. BMO Capital Markets currently has a market perform rating on the stock.
Zimmer Biomet (NYSE:ZBH) had its target price boosted by Stifel Nicolaus from $125.00 to $140.00. They currently have a buy rating on the stock.
Zevra Therapeutics (NASDAQ:ZVRA) had its target price lowered by Guggenheim from $23.00 to $18.00. The firm currently has a buy rating on the stock.
Receive News & Ratings for AbbVie Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AbbVie Inc and related companies with MarketBeat.com's FREE daily email newsletter.
